GABAPENTIN | A077662 | GLENMARK PHARMACEUTICALS LTD
Highest NADAC/Unit
$0.0900
per ea
Lowest NADAC/Unit
$0.0638
per ea
Brand NDCs
0
Generic NDCs
8
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 68462012701GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68462012705GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68001041200GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68001041203GABAPENTIN 800 MG TABLET | $0.0900 | EA | Generic | — | 2026-08-19 |
| 68001041100GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
| 68462012605GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
| 68462012601GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
| 68001041103GABAPENTIN 600 MG TABLET | $0.0638 | EA | Generic | — | 2026-08-19 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.